[HTML][HTML] Immune checkpoint inhibitors in non-small cell lung cancer: From current perspectives to future treatments—A systematic review
A Olivares-Hernández, EG Del Portillo… - Annals of …, 2023 - ncbi.nlm.nih.gov
Background The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments-a systematic review.
A Olivares-Hernández… - Annals of …, 2023 - europepmc.org
Background The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
[PDF][PDF] Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
A Olivares-Hernández, EG del Portillo… - 2023 - cdn.amegroups.cn
Background: The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments-a systematic review
A Olivares-Hernández… - Annals of …, 2023 - pubmed.ncbi.nlm.nih.gov
Background The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
[HTML][HTML] Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
A Olivares-Hernández, EG del Portillo… - Annals of …, 2023 - atm.amegroups.org
Background: The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
[PDF][PDF] Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
A Olivares-Hernández, EG del Portillo… - 2023 - cdn.amegroups.cn
Background: The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
[引用][C] Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
A Olivares-Hernández, EG del Portillo… - Annals of …, 2023 - atm.amegroups.org
Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future
treatments—a systematic review - Olivares-Hernández - Annals of Translational Medicine …
treatments—a systematic review - Olivares-Hernández - Annals of Translational Medicine …
[引用][C] Immune checkpoint inhibitors in non-small cell lung cancer: from current perspectives to future treatments—a systematic review
A Olivares-Hernández, EG del Portillo… - 2023 - europepmc.org
Background: The introduction of immunotherapy in the treatment of non-small cell lung
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …
cancer (NSCLC) has resulted in a radical change in patients' treatment responses and …